In the clinical trial NCT03693781, Colchicine was used to enhance autophagy to reduce TDP-43 accumulation in neurons, and alleviate ALS symptoms through its anti-inflammatory function. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.